hyaluronoglucosaminidase has been researched along with Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Albanese, C | 1 |
| Hällgren, R; Johnsson, C; Tufveson, G | 1 |
3 other study(ies) available for hyaluronoglucosaminidase and Cardiomyopathies
| Article | Year |
|---|---|
Pertuzumab, Trastuzumab and Hyaluronidase-zzxf.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiomyopathies; Female; Fetal Diseases; Humans; Hyaluronoglucosaminidase; Lung Diseases; Pregnancy; Trastuzumab | 2020 |
[Hyaluronidase treatment of acute myocardial infarct].
Topics: Cardiomyopathies; Humans; Hyaluronoglucosaminidase | 1983 |
Hyaluronidase can be used to reduce interstitial edema in the presence of heparin.
Topics: Animals; Anticoagulants; Bleeding Time; Cardiomyopathies; Cattle; Dose-Response Relationship, Drug; Edema; Extracellular Space; Graft Rejection; Heart Transplantation; Heparin; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Rats; Rats, Inbred WKY | 2000 |